MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: May 22, 2025 · CIK: 1878313
Sentiment: neutral
Topics: corporate-action, filing, financials
TL;DR
MAIA Bio filed an 8-K on 5/22/25 covering votes, events, and financials.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on May 22, 2025, reporting on matters submitted to a vote of security holders, other events, and financial statements/exhibits. The filing does not contain specific details on the votes, events, or financial figures within the provided text.
Why It Matters
This filing indicates MAIA Biotechnology is providing updates to the SEC regarding corporate actions and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not contain information about significant risks or negative events.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- May 22, 2025 (date) — Date of earliest event reported
- 001-41455 (other) — SEC File Number
- Delaware (other) — State of incorporation
- 444 West Lake Street, Suite 1700 (other) — Principal executive offices address
- Chicago, IL 60606 (other) — Principal executive offices location
- 312-416-8592 (other) — Registrant's telephone number
FAQ
What specific matters were submitted to a vote of MAIA Biotechnology's security holders?
The provided text of the 8-K filing does not specify the exact matters submitted to a vote of security holders.
What 'Other Events' are being reported by MAIA Biotechnology in this 8-K?
The filing indicates 'Other Events' are reported, but the specific details of these events are not included in the provided text.
Are there any financial statements or exhibits included with this 8-K filing?
Yes, the filing explicitly lists 'Financial Statements and Exhibits' as an item information, though the content of these is not detailed in the provided text.
When was this 8-K report filed with the SEC?
This 8-K report was filed on May 22, 2025.
What is MAIA Biotechnology, Inc.'s principal executive office address?
MAIA Biotechnology, Inc.'s principal executive office is located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding MAIA Biotechnology, Inc. (MAIA).